Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

LabioTech

December 10, 2016

These are 10 of the Hottest Biotech Hubs in Europe

Reuters

December 8, 2016

ABIVAX provides update on clinical development program for functional cure of patients with HIV-infection

FierceBiotech

September 15, 2016

Abivax, buoyed by HIV milestone, leads surge in value of biotech stocks in Paris

LabioTech

July 4, 2016

“We have one of the World’s Most Advanced Functional HIV Cures under development”

Reuters

April 19, 2016

Abivax gets clearance in Spain for second phase IIa trial in HIV/AIDS patients

  • 1
  • 2

References available upon request.

© 2025 All rights reserved by Abivax 06/2025 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn